Monopar Therapeutics Inc (MNPR) — Strategic Asset Allocation Index
Monopar Therapeutics Inc (MNPR) has a Strategic Asset Allocation Index of 0.5% as of June 2023. Strategic assets (PP&E of $37.33K plus long-term investments of $-) total $37.33K, measured against net assets of $7.84 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Monopar Therapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Monopar Therapeutics Inc (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Monopar Therapeutics Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Monopar Therapeutics Inc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|